Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines

Por Klepser, Michael E.
Publicado em 2014

Variation in Electrophoretic Karyotype and Antifungal Susceptibility of Clinical Isolates of Cryptococcus neoformans at a University-Affiliated Teaching Hospital from 1987 to 1994

Por Klepser, Michael E., Pfaller, Michael A.
Publicado em 1998

Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformans

Por Ernst, Erika J., Klepser, Michael E., Pfaller, Michael A.
Publicado em 2000

In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp.

Por Lewis, Russell E., Wiederhold, Nathan P., Klepser, Michael E.
Publicado em 2005

Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections

Por Zoller, Emily, Valente, Connie, Baker, Kyle, Klepser, Michael E
Publicado em 2010

Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis

Por Daddario, Martha K, Hagerman, Jennifer K, Klepser, Michael E
Publicado em 2010

Rates and Extents of Antifungal Activities of Amphotericin B, Flucytosine, Fluconazole, and Voriconazole against Candida lusitaniae Determined by Microdilution, Etest, and Time-Kil...

Por Ernst, Erika J., Yodoi, Keiko, Roling, Ellen E., Klepser, Michael E.
Publicado em 2002

Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology

Por Klepser, Michael E., Malone, Dennis, Lewis, Russell E., Ernst, Erika J., Pfaller, Michael A.
Publicado em 2000

In Vitro Pharmacodynamic Characteristics of Nystatin Including Time-Kill and Postantifungal Effect

Por Gunderson, Shana M., Hoffman, Holly, Ernst, Erika J., Pfaller, Michael A., Klepser, Michael E.
Publicado em 2000

Comparative Bactericidal Activities of Ciprofloxacin, Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against Streptococcus pneumoniae in a Dynamic In...

Por Klepser, Michael E., Ernst, Erika J., Petzold, C. Rosemarie, Rhomberg, Paul, Doern, Gary V.
Publicado em 2001

Assessment of Antifungal Activities of Fluconazole and Amphotericin B Administered Alone and in Combination against Candida albicans by Using a Dynamic In Vitro Mycotic Infection...

Por Lewis, Russell E., Lund, Brian C., Klepser, Michael E., Ernst, Erika J., Pfaller, Michael A.
Publicado em 1998

Evaluation of Endpoints for Antifungal Susceptibility Determinations with LY303366

Por Klepser, Michael E., Ernst, Erika J., Ernst, Michael E., Messer, Shawn A., Pfaller, Michael A.
Publicado em 1998

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Por Klepser, Michael E., Ernst, Erika J., Lewis, Russell E., Ernst, Michael E., Pfaller, Michael A.
Publicado em 1998

In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies

Por Ernst, Erika J., Roling, Ellen E., Petzold, C. Rosemarie, Keele, Douglas J., Klepser, Michael E.
Publicado em 2002

Evaluation of Low-Dose, Extended-Interval Clindamycin Regimens against Staphylococcus aureus and Streptococcus pneumoniae Using a Dynamic In Vitro Model of Infection

Por Lewis, Russell E., Klepser, Michael E., Ernst, Erika J., Lund, Brian C., Biedenbach, Douglas J., Jones, Ronald N.
Publicado em 1999

Influence of Macrolide Susceptibility on Efficacies of Clarithromycin and Azithromycin against Streptococcus pneumoniae in a Murine Lung Infection Model

Por Hoffman, Holly L., Klepser, Michael E., Ernst, Erika J., Petzold, C. Rosemarie, Sa'adah, Loai Mohammed, Doern, Gary V.
Publicado em 2003